Pharmaceutical

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

The lawsuit filings are the latest turn in a long-running legal saga between GLP-1RAs makers and compounders.

Apr 24, 2025 - 06:00
Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing
The lawsuit filings are the latest turn in a long-running legal saga between GLP-1RAs makers and compounders.
Read the original article

Tags:

Previous Article

Biogen’s Friedreich’s ataxia treatment authorised in UK

Next Article

Veraxa to go public in $1.6bn SPAC deal with Voyager

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Boehringer reinforces interest in NASH with new $2bn deal  

Boehringer reinforces interest in NASH with new $2bn de...

Jan 3, 2024

STAT+: Banning surprise medical bills is raising costs elsewhere

STAT+: Banning surprise medical bills is raising costs ...

Feb 17, 2024

Arrowhead and Sarepta link for rare genetic disease treatments

Arrowhead and Sarepta link for rare genetic disease tre...

Nov 27, 2024